ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0433

Racial Disparities and New SLE-Specific Predictors of Stroke and Ischemic Heart Disease in Patients with Lupus

Shivani Garg1, Christie Bartels2, Gaobin Bao3, Cristina Drenkard4 and S. Sam Lim3, 1UW Madison, Madison, WI, 2University of Wisconsin School of Medicine and Public Health, Department of Medicine, Division of Rheumatology, Madison, WI, 3Emory University, Atlanta, GA, 4Division of Rheumatology, Department of Medicine, Emory School of Medicine, Atlanta, GA

Meeting: ACR Convergence 2020

Keywords: Disparities, Heart disease, risk factors, Stroke, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Friday, November 6, 2020

Title: Plenary Session I (0429–0433)

Session Type: Plenary Session

Session Time: 11:30AM-1:00PM

Background/Purpose: In the US, cardiovascular disease (CVD) is the leading cause of disparities in life expectancy between black and white populations. We recently reported a 19-fold higher occurrence of CVD in blacks with SLE compared to non-blacks and noted disproportionately high stroke-related events around the time of SLE diagnosis. This study measured the risk and predictors of stroke and ischemic heart disease (IHD) in a predominantly black, population-based, incident cohort.

Methods: The Georgia Lupus Registry (GLR) is a population-based registry of SLE patients from Atlanta, Georgia. Incident patients in 2002-04 met ≥4 ACR SLE criteria or 3 criteria with a final diagnosis of SLE by their board-certified rheumatologist. Patients were matched to the Georgia Hospital Discharge Database and National Death Index from 2000-13. Stroke- and IHD-related hospitalizations and deaths were classified by the first three admission or cause of death codes. Stroke also included transient ischemic attack, and IHD included myocardial infarction and angina. Predictors of strokes and IHD were examined using Cox proportional hazards models.

Results: Among 336 incident SLE patients, 87% were female, 75% were black patient with a mean age at SLE diagnosis of 40 ± 17 years. There were 38 stroke-related and 25 IHD-related events or deaths, from the period 2 years before through 14 years after SLE diagnosis.

In the 11% with strokes, the mean age at first stroke was 48 years, with 78% occurring in females and 90% in blacks. The peak number of strokes occurred during the 2nd year after SLE diagnosis. We noted 8% had IHD, the mean age at first IHD was 52 years, with all occurring in females and 96% in blacks. The peak number of IHD occurred in the 14th year after SLE diagnosis.

Blacks had a 3-fold higher risk for stroke (HR 3.4, 95% CI 1.2-10, p 0.03) and a 24-fold higher risk for IHD (HR 24, 95% CI 3-206, p 0.004) (Table 1 & 2). Discoid rash at SLE diagnosis predicted a 5-fold (HR 4.6, 95% CI 1.7-13, p 0.003) and renal disorder predicted a 2-fold higher risk for stroke (HR 2.4, 95% CI 1.1-2.5, p 0.04) (Table 1). Neither impacted IHD (Table 2). Neurologic (HR 4.0, 95% CI 1.3-13, p 0.02) and immunologic disorder (HR 4.7, 95% CI 1.3-18, p 0.02) (Table 2) were strong predictors of IHD but not stroke.

Race stratified Cox proportional hazard models showed significantly accelerated stroke and IHD events in black compared to non-black patients (p ≤ 0.001) (Figure 1A & B).

Conclusion: We found a 3-fold higher risk of stroke and 24-fold higher risk of IHD in blacks with SLE. We found different SLE-specific predictors of stroke and IHD: discoid rash and renal disorder predicted stroke, and neurologic and immunologic disorder strongly predicted IHD. This study provides unique insights on significantly different SLE-disease related predictors, timing and racial disparities in stroke compared to IHD in SLE. Hence, we highlight the need to consider different preventive strategies for stroke and IHD in SLE.

Table 1. Predictors of Incident Stroke in Systemic Lupus Patients in the Georgia Lupus Registry

Table 2. Predictors of Incident Ischemic Heart Disease (IHD) Occurrence

Figure 1 Race Stratified: Panel A) Stroke-Event Free Survival, Panel B) IHD-Event Free Survival


Disclosure: S. Garg, None; C. Bartels, Independent Grants for Learning and Change (Pfizer), 2; G. Bao, None; C. Drenkard, None; S. Lim, None.

To cite this abstract in AMA style:

Garg S, Bartels C, Bao G, Drenkard C, Lim S. Racial Disparities and New SLE-Specific Predictors of Stroke and Ischemic Heart Disease in Patients with Lupus [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/racial-disparities-and-new-sle-specific-predictors-of-stroke-and-ischemic-heart-disease-in-patients-with-lupus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/racial-disparities-and-new-sle-specific-predictors-of-stroke-and-ischemic-heart-disease-in-patients-with-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology